Watch “Estradiol: The Pendulum Is Swinging”, as Belmar Pharma Solutions Medical Director, Angela DeRosa, DO, MBA, CPE, and Belmar’s Director of Women’s Health, Andi Roths, PharmD, discuss several current studies on estrogen.
In this webinar, you will learn:
- About the events leading up to FDA’s decision to instruct drug manufacturers to remove the “black box” warning from most estrogen products
- What this decision means for clinicians and patients; overturning previously instilled fears about harmful side effects/breast cancer
- How this decision affects the role of compounded medications–highly personalized for individual patients; available dosage forms
- The role of estradiol in preventing diseases long term, including cardiovascular risk
- Differences between bioidentical estradiol vs. synthetic forms of estrogen
- Educational gaps and responsible prescribing of estrogen hormones
Review these articles to be a part of the discussion:
- https://www.sciencedirect.com/science/article/abs/pii/S003306202400015X
- https://ascopubs.org/doi/10.1200/OP.21.00343
- https://www.maturitas.org/article/S0378-5122(23)00066-X/fulltext
Watch on-demand today.
This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.
